Jackson Grant Investment Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Buy
12,533
+49
+0.4% +$5.74K 0.5% 39
2026
Q1
$1.5M Sell
12,484
-972
-7% -$112K 0.5% 37
2025
Q4
$1.42M Buy
13,456
+798
+6% +$74.9K 0.47% 39
2025
Q3
$1.06M Buy
12,658
+592
+5% +$48.8K 0.35% 43
2025
Q2
$955K Buy
12,066
+65
+0.5% +$5.17K 0.35% 44
2025
Q1
$1.08M Buy
12,001
+56
+0.5% +$5.23K 0.42% 40
2024
Q4
$1.19M Buy
11,945
+48
+0.4% +$4.95K 0.46% 38
2024
Q3
$1.35M Buy
11,897
+41
+0.3% +$4.87K 0.51% 35
2024
Q2
$1.47M Buy
11,856
+297
+3% +$38.3K 0.59% 30
2024
Q1
$1.53M Buy
11,559
+53
+0.5% +$6.53K 0.62% 28
2023
Q4
$1.25M Buy
11,506
+55
+0.5% +$5.71K 0.56% 32
2023
Q3
$1.18M Buy
11,451
+51
+0.4% +$5.5K 0.57% 34
2023
Q2
$1.32M Buy
11,400
+51
+0.4% +$5.79K 0.61% 32
2023
Q1
$1.21M Buy
11,349
+100
+0.9% +$10.8K 0.57% 33
2022
Q4
$1.25M Buy
11,249
+59
+0.5% +$6.03K 0.6% 31
2022
Q3
$964K Buy
11,190
+56
+0.5% +$5K 0.5% 35
2022
Q2
$1.01M Buy
11,134
+97
+0.9% +$8.6K 0.5% 36
2022
Q1
$906K Buy
11,037
+72
+0.7% +$5.68K 0.38% 41
2021
Q4
$840K Buy
10,965
+62
+0.6% +$4.94K 0.43% 38
2021
Q3
$819K Buy
10,903
+61
+0.6% +$4.64K 0.36% 41
2021
Q2
$843K Sell
10,842
-447
-4% -$33.2K 0.37% 41
2021
Q1
$830K Buy
11,289
+555
+5% +$40.9K 0.38% 42
2020
Q4
$838K Buy
10,734
+61
+0.6% +$4.67K 0.43% 37
2020
Q3
$845K Buy
10,673
+63
+0.6% +$4.93K 0.51% 33
2020
Q2
$783K Buy
10,610
+64
+0.6% +$4.82K 0.5% 34
2020
Q1
$774K Buy
10,546
+53
+0.5% +$4.17K 0.57% 30
2019
Q4
$911K Buy
10,493
+159
+2% +$13.1K 0.49% 33
2019
Q3
$830K Buy
10,334
+51
+0.5% +$4.09K 0.47% 33
2019
Q2
$823K Buy
10,283
+51
+0.5% +$3.9K 0.48% 33
2019
Q1
$812K Buy
10,232
+36
+0.4% +$2.69K 0.49% 33
2018
Q4
$743K Buy
10,196
+268
+3% +$18.9K 0.52% 33
2018
Q3
$672K Buy
9,928
+77
+0.8% +$4.91K 0.42% 39
2018
Q2
$571K Sell
9,851
-345
-3% -$19.5K 0.39% 38
2018
Q1
$530K Sell
10,196
-435
-4% -$23.5K 0.37% 39
2017
Q4
$571K Sell
10,631
-225
-2% -$12.5K 0.39% 41
2017
Q3
$663K Buy
10,856
+1,119
+11% +$67.8K 0.48% 34
2017
Q2
$595K Buy
9,737
+41
+0.4% +$2.5K 0.46% 34
2017
Q1
$588K Buy
9,696
+39
+0.4% +$2.37K 0.47% 32
2016
Q4
$542K Buy
9,657
+4,023
+71% +$235K 0.46% 34
2016
Q3
$336K Buy
5,634
+149
+3% +$8.71K 0.28% 42
2016
Q2
$302K Buy
5,485
+46
+0.8% +$2.45K 0.27% 42
2016
Q1
$275K Buy
5,439
+249
+5% +$12.2K 0.25% 48
2015
Q4
$262K Buy
+5,190
New +$262K 0.25% 49

Other funds holding MRK

Jackson Grant Investment Advisers's MRK Position: Q2 2026 in Review

Jackson Grant Investment Advisers increased its Merck (MRK) stake by 0.39% in Q2 2026, buying an estimated $5.74K and bringing the position to 12,533 shares worth $1.61M. The position accounts for 0.5% of the portfolio, ranked #39.

Jackson Grant Investment Advisers first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. 1,860 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Jackson Grant Investment Advisers held 12,533 shares of Merck worth $1.61M as of Q2 2026.
  • Jackson Grant Investment Advisers bought 49 Merck shares in Q2 2026, an estimated $5.74K.
  • Merck made up 0.5% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #39 holding.
  • Jackson Grant Investment Advisers first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
  • 1,860 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.